Hoth Therapeutics Inc (NASDAQ:HOTH)’s traded shares stood at 1.18 million during the last session, with the company’s beta value hitting 0.73. At the close of trading, the stock’s price was $1.58, to imply an increase of 4.64% or $0.07 in intraday trading. The HOTH share’s 52-week high remains $3.80, putting it -140.51% down since that peak but still an impressive 63.29% since price per share fell to its 52-week low of $0.58. The company has a valuation of $10.90M, with an average of 50.0 million shares in intraday trading volume over the past 10 days and average of 8.97 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Hoth Therapeutics Inc (HOTH), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give HOTH a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.26.
Hoth Therapeutics Inc (NASDAQ:HOTH) trade information
After registering a 4.64% upside in the last session, Hoth Therapeutics Inc (HOTH) has traded red over the past five days. The 5-day price performance for the stock is -16.84%, and 95.06% over 30 days. With these gigs, the year-to-date price performance is 111.20%. Short interest in Hoth Therapeutics Inc (NASDAQ:HOTH) saw shorts transact 0.63 million shares and set a 1.16 days time to cover.
Hoth Therapeutics Inc (HOTH) estimates and forecasts
Looking at statistics comparing Hoth Therapeutics Inc share performance against respective industry, we note that the company has outperformed competitors. Hoth Therapeutics Inc (HOTH) shares are 68.10% up over the last 6 months, with its year-to-date growth rate higher than industry average at 48.70% against 16.70%.
HOTH Dividends
Hoth Therapeutics Inc has its next earnings report out in February. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Hoth Therapeutics Inc (NASDAQ:HOTH)’s Major holders
Hoth Therapeutics Inc insiders hold 0.92% of total outstanding shares, with institutional holders owning 5.31% of the shares at 5.36% float percentage. In total, 5.31% institutions holds shares in the company.
We also have Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Hoth Therapeutics Inc (HOTH) shares. Going by data provided on Sep 30, 2024 , Vanguard Extended Market Index Fund holds roughly 38.8 shares. This is just over 0.56% of the total shares, with a market valuation of $61310.0. Data from the same date shows that the other fund manager holds a little less at 35.83, or 0.52% of the shares, all valued at about 56617.0.
